Most Recent

image: Opinion: After We March

Opinion: After We March

By | March 16, 2017

How to become—and stay—involved in science policy 

4 Comments

image: Opinion: Sometimes, Scientists Must March

Opinion: Sometimes, Scientists Must March

By , , and | February 13, 2017

Lessons learned from the “Death of Evidence” demonstration in Canada

9 Comments

Mentoring is critical for students just beginning to learn the ropes of biomedical research.

5 Comments

image: Opinion: Experiences of an Itinerant Scientist

Opinion: Experiences of an Itinerant Scientist

By | July 14, 2015

What I’ve learned doing science in three different countries 

1 Comment

image: Opinion: How Postdocs Can Participate

Opinion: How Postdocs Can Participate

By | September 18, 2014

Graduate students and postdoctoral researchers should be taking part in discussions on the future of biomedical research.

6 Comments

image: Opinion: A Role for Community Science Clubs

Opinion: A Role for Community Science Clubs

By , , and | July 29, 2014

How retired scientists can enhance science education where they reside

2 Comments

image: Opinion: The Pitfalls of Uncertainty

Opinion: The Pitfalls of Uncertainty

By | April 14, 2014

How to successfully inform policy when scientific evidence is not plainly evident.

2 Comments

image: Opinion: Video Saved the Scientific Publication

Opinion: Video Saved the Scientific Publication

By | November 11, 2013

How visual materials and methods can save scientists time and money.

2 Comments

image: Opinion: The Best Projects Are Least Obvious

Opinion: The Best Projects Are Least Obvious

By | September 25, 2013

Today’s technologies have opened all sorts of experimental avenues. Deciding which questions are best to pursue requires a certain degree of restraint.

1 Comment

image: Opinion: Rebuffing RAS Reform

Opinion: Rebuffing RAS Reform

By | September 19, 2013

On the impending changes to the Russian Academy of Sciences

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS